Analytical capabilities supporting a variety of product types
We have analytical capabilities and expertise that encompass a wide range of technologies to support all stages of product and process development. These have been applied to monoclonal antibodies, antibody fragments, fusion proteins, chemically conjugated proteins, hormones and enzymes. Validated analytical methods are available to support release of early phase clinical material. These methods have also been successfully used to support license applications following product specific validation.
Our analytical experience is applied to support a range of methods including: